KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vertex Pharmaceuticals (VRTX) Net Income - Minority (2016 - 2018)

Historic Net Income - Minority for Vertex Pharmaceuticals (VRTX) over the last 8 years, with Q3 2018 value amounting to -$28.4 million.

  • Vertex Pharmaceuticals' Net Income - Minority fell 13313.06% to -$28.4 million in Q3 2018 from the same period last year, while for Sep 2018 it was -$28.4 million, marking a year-over-year decrease of 13313.06%. This contributed to the annual value of -$13.7 million for FY2017, which is 9244.15% up from last year.
  • As of Q3 2018, Vertex Pharmaceuticals' Net Income - Minority stood at -$28.4 million, which was down 13313.06% from -$28.7 million recorded in Q2 2018.
  • In the past 5 years, Vertex Pharmaceuticals' Net Income - Minority ranged from a high of -$12.2 million in Q3 2017 and a low of -$196.0 million during Q2 2017
  • Its 5-year average for Net Income - Minority is -$106.9 million, with a median of -$153.5 million in 2015.
  • Per our database at Business Quant, Vertex Pharmaceuticals' Net Income - Minority plummeted by 65486.98% in 2016 and then surged by 9348.64% in 2017.
  • Vertex Pharmaceuticals' Net Income - Minority (Quarter) stood at -$21.2 million in 2014, then crashed by 625.6% to -$153.7 million in 2015, then decreased by 18.19% to -$181.6 million in 2016, then surged by 92.44% to -$13.7 million in 2017, then tumbled by 106.64% to -$28.4 million in 2018.
  • Its last three reported values are -$28.4 million in Q3 2018, -$28.7 million for Q2 2018, and -$29.8 million during Q1 2018.